AAPG$13.685.37%-0.7765
Ascentage Pharma Group International Adr (AAPG)
Date: 2026-11-02 16:00O: 14.23H: 14.23L: 13.46C: 13.68Vol: 4.300k
Ascentage Pharma Group International Adr stock is traded at $13.68, with a volume of 5,199. It is down -5.37% in the last 24 hours and down -10.97% over the past month. Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.
Previous Close:
$14.46
Open:
$14.23
24h Volume:
5,199
Relative Volume:
0.62
Market Cap:
$1.28B
Revenue:
$80.00M
Net Income/Loss:
-$172.98M
P/E Ratio:
-
EPS:
-$1.94
Net Cash Flow:
-$178.54M
1W Performance:
-11.46%
1M Performance:
-10.97%
6M Performance:
-41.39%
1Y Performance:
-59.07%
1-Day Range:
$13.46$14.23
1-Week Range:
$13.99$15.25
52-Week Range:
$13.46$35.86
Ascentage Pharma Group International Adr Stock (AAPG) Company Profile
Compare AAPG vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|
AAPG Ascentage Pharma Group International Adr | $1.28B | $80.00M | -$172.98M | -$178.54M | -$1.94 |
 VRTX Vertex Pharmaceuticals Inc | $139.51B | $12.59B | $4.41B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $99.76B | $16.90B | $4.82B | $3.79B | $41.04 |
 MRNA Moderna Inc | $87.92B | $2.23B | -$3.15B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $55.01B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $40.95B | $6.13B | $655.71M | $1.10B | $4.48 |
Ascentage Pharma Group International Adr Stock (AAPG) Upgrades & Downgrades
Ascentage Pharma Group International Adr Stock (AAPG) Financials Data
There is no financial data for Ascentage Pharma Group International Adr (AAPG). Check out other stocks for more information.
Ascentage Pharma Group International Adr Stock (AAPG) Insider Trading
- Zhai YifanMay 21 '26Chief Medical Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 92,746
- Value ($)
- 0
- #Shares Total
- 405,280
- Yang DajunMay 21 '26Chairman and CEO
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 92,746
- Value ($)
- 0
- #Shares Total
- 405,280
- Yang DajunMay 21 '26Chairman and CEO
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 95,575
- Value ($)
- 0
- #Shares Total
- 1,193,569
